Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tariquidar and Docetaxel in Advanced Cancer
NCT00069160Phase 2Completed
- Sponsor
- National Cancer Institute
- Start
- Sep 2003
- Primary completion
- Dec 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of tariquidar in lung cancer, ovarian cancer, Cervical Cancer (CC), renal cell carcinoma (RCC), sponsored by National Cancer Institute. Started Sep 2003; status: completed.
02
Drugs
tariquidar
03
Conditions
lung cancerovarian cancerCervical Cancer (CC)renal cell carcinoma (RCC)
Beyond the preview
Go deeper on NCT00069160.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00069160.